Market Dynamics:

The Eczema Therapeutics Market is witnessing high growth owing to the increasing prevalence of atopic dermatitis globally. As per an article published by National Eczema Association, over 31 million Americans and 7-10% of children in the United States are impacted by eczema. Further, according to the Global Burden of Disease study, the global prevalence of atopic dermatitis has increased by 200% between the years 1990 and 2017. The growing cases of atopic dermatitis, mainly in children populations, is a key factor driving the demand for effective eczema therapeutics such as topical corticosteroids and calcineurin inhibitors. Furthermore, various clinical trials underway for new drug molecules and biologics to treat moderate to severe eczema are expected to offer lucrative growth opportunities for players in the market during the forecast period.

Key Takeaways
The Global Eczema Therapeutics Market Size is expected to witness high growth driven by rising incidence rates attributed to changing environmental and lifestyle factors. The market size is projected to reach $33,093.37 Mn by 2030 from $19,074.46 Mn in 2023 registering a CAGR of 11%.

For More Insights, Read: https://techcatalyst26.weebly.com/blog/eczema-therapeutics-market-is-estimated-to-witness-high-growth-owing-to-opportunity-of-rising-prevalence-of-atopic-dermatitis